Literature DB >> 35163141

Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders.

Anna Morozova1,2, Yana Zorkina1,2, Olga Abramova1,2, Olga Pavlova2, Konstantin Pavlov2, Kristina Soloveva1, Maria Volkova1, Polina Alekseeva1, Alisa Andryshchenko1, Georgiy Kostyuk1, Olga Gurina2, Vladimir Chekhonin2,3.   

Abstract

This review is focused on several psychiatric disorders in which cognitive impairment is a major component of the disease, influencing life quality. There are plenty of data proving that cognitive impairment accompanies and even underlies some psychiatric disorders. In addition, sources provide information on the biological background of cognitive problems associated with mental illness. This scientific review aims to summarize the current knowledge about neurobiological mechanisms of cognitive impairment in people with schizophrenia, depression, mild cognitive impairment and dementia (including Alzheimer's disease).The review provides data about the prevalence of cognitive impairment in people with mental illness and associated biological markers.

Entities:  

Keywords:  Alzheimer’s disease; MCI; SNP; biomarkers; cognitions; depression; epigenetic regulation; neuroinflammatory; psychiatric disorder; schizophrenia

Mesh：

Year:  2022        PMID： 35163141      PMCID： PMC8835608          DOI： 10.3390/ijms23031217

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN： 1422-0067            Impact factor:   5.923


  339 in total

Review 1.  Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics.

Authors:  A G Cardno; I I Gottesman
Journal:  Am J Med Genet       Date:  2000

Review 2.  Histones and histone modifications.

Authors:  Craig L Peterson; Marc-André Laniel
Journal:  Curr Biol       Date:  2004-07-27       Impact factor: 10.834

3.  Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.

Authors:  Hlin Kvartsberg; Flora H Duits; Martin Ingelsson; Niels Andreasen; Annika Öhrfelt; Kerstin Andersson; Gunnar Brinkmalm; Lars Lannfelt; Lennart Minthon; Oskar Hansson; Ulf Andreasson; Charlotte E Teunissen; Philip Scheltens; Wiesje M Van der Flier; Henrik Zetterberg; Erik Portelius; Kaj Blennow
Journal:  Alzheimers Dement       Date:  2014-12-19       Impact factor: 21.566

Review 4.  Accuracy of urinary AD7c-NTP for diagnosing Alzheimer's disease: a systematic review and meta-analysis.

Authors:  Jian Zhang; Chun-Hua Zhang; Rong-Jie Li; Xiao-Li Lin; Ying-Dao Chen; Huai-Qing Gao; Sheng-Liang Shi
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

5.  Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.

Authors:  M L Selley
Journal:  Neurobiol Aging       Date:  2003-11       Impact factor: 4.673

6.  Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

Authors:  R W Heinrichs; K K Zakzanis
Journal:  Neuropsychology       Date:  1998-07       Impact factor: 3.295

7.  A mega-analysis of genome-wide association studies for major depressive disorder.

Authors:  Stephan Ripke; Naomi R Wray; Cathryn M Lewis; Steven P Hamilton; Myrna M Weissman; Gerome Breen; Enda M Byrne; Douglas H R Blackwood; Dorret I Boomsma; Sven Cichon; Andrew C Heath; Florian Holsboer; Susanne Lucae; Pamela A F Madden; Nicholas G Martin; Peter McGuffin; Pierandrea Muglia; Markus M Noethen; Brenda P Penninx; Michele L Pergadia; James B Potash; Marcella Rietschel; Danyu Lin; Bertram Müller-Myhsok; Jianxin Shi; Stacy Steinberg; Hans J Grabe; Paul Lichtenstein; Patrik Magnusson; Roy H Perlis; Martin Preisig; Jordan W Smoller; Kari Stefansson; Rudolf Uher; Zoltan Kutalik; Katherine E Tansey; Alexander Teumer; Alexander Viktorin; Michael R Barnes; Thomas Bettecken; Elisabeth B Binder; René Breuer; Victor M Castro; Susanne E Churchill; William H Coryell; Nick Craddock; Ian W Craig; Darina Czamara; Eco J De Geus; Franziska Degenhardt; Anne E Farmer; Maurizio Fava; Josef Frank; Vivian S Gainer; Patience J Gallagher; Scott D Gordon; Sergey Goryachev; Magdalena Gross; Michel Guipponi; Anjali K Henders; Stefan Herms; Ian B Hickie; Susanne Hoefels; Witte Hoogendijk; Jouke Jan Hottenga; Dan V Iosifescu; Marcus Ising; Ian Jones; Lisa Jones; Tzeng Jung-Ying; James A Knowles; Isaac S Kohane; Martin A Kohli; Ania Korszun; Mikael Landen; William B Lawson; Glyn Lewis; Donald Macintyre; Wolfgang Maier; Manuel Mattheisen; Patrick J McGrath; Andrew McIntosh; Alan McLean; Christel M Middeldorp; Lefkos Middleton; Grant M Montgomery; Shawn N Murphy; Matthias Nauck; Willem A Nolen; Dale R Nyholt; Michael O'Donovan; Högni Oskarsson; Nancy Pedersen; William A Scheftner; Andrea Schulz; Thomas G Schulze; Stanley I Shyn; Engilbert Sigurdsson; Susan L Slager; Johannes H Smit; Hreinn Stefansson; Michael Steffens; Thorgeir Thorgeirsson; Federica Tozzi; Jens Treutlein; Manfred Uhr; Edwin J C G van den Oord; Gerard Van Grootheest; Henry Völzke; Jeffrey B Weilburg; Gonneke Willemsen; Frans G Zitman; Benjamin Neale; Mark Daly; Douglas F Levinson; Patrick F Sullivan
Journal:  Mol Psychiatry       Date:  2012-04-03       Impact factor: 15.992

Review 8.  The assessment of neuropsychological functioning in schizophrenia.

Authors:  Abraham Reichenberg
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

Review 9.  Schizophrenia.

Authors:  Michael J Owen; Akira Sawa; Preben B Mortensen
Journal:  Lancet       Date:  2016-01-15       Impact factor: 79.321

Review 10.  Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer.

Authors:  Luca Colucci-D'Amato; Luisa Speranza; Floriana Volpicelli
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923
View more
  5 in total

1.  BRAINCODE for Cognitive Impairment Diagnosis in Older Adults: Designing a Case-Control Pilot Study.

Authors:  Pedro Rocha; Paulina Clara Dagnino; Ronan O'Sullivan; Aureli Soria-Frisch; Constança Paúl
Journal:  Int J Environ Res Public Health       Date:  2022-05-09       Impact factor: 4.614

2.  Impact of Behavioral Assessment and Re-Test as Functional Trainings That Modify Survival, Anxiety and Functional Profile (Physical Endurance and Motor Learning) of Old Male and Female 3xTg-AD Mice and NTg Mice with Normal Aging.

Authors:  Lidia Castillo-Mariqueo; Lydia Giménez-Llort
Journal:  Biomedicines       Date:  2022-04-22

Review 3.  A Narrative Review of the Effects of Citrus Peels and Extracts on Human Brain Health and Metabolism.

Authors:  Kentaro Matsuzaki; Akira Nakajima; Yuanqiang Guo; Yasushi Ohizumi
Journal:  Nutrients       Date:  2022-04-28       Impact factor: 6.706

4.  Metabolic risk factors of cognitive impairment in young women with major psychiatric disorder.

Authors:  Chuanjun Zhuo; Wei Liu; Ronghuan Jiang; Ranli Li; Haiping Yu; Guangdong Chen; Jianmin Shan; Jingjing Zhu; Ziyao Cai; Chongguang Lin; Langlang Cheng; Yong Xu; Sha Liu; Qinghua Luo; Shili Jin; Chuanxin Liu; Jiayue Chen; Lina Wang; Lei Yang; Qiuyu Zhang; Qianchen Li; Hongjun Tian; Xueqin Song
Journal:  Front Psychiatry       Date:  2022-07-29       Impact factor: 5.435

Review 5.  The emerging role of furin in neurodegenerative and neuropsychiatric diseases.

Authors:  Yi Zhang; Xiaoqin Gao; Xue Bai; Shanshan Yao; Yan-Zhong Chang; Guofen Gao
Journal:  Transl Neurodegener       Date:  2022-08-23       Impact factor: 9.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.